Burford Capital Limited (BUR) Dividend History

Burford Capital Limited (BUR) is a global finance and investment firm that specializes in legal finance and risk management. It provides funding and other capital solutions to law firms, corporations, and government entities involved in complex litigation and arbitration cases. The company aims to offer strategic financing options to support high-value legal disputes while generating attractive returns for its investors.

Dividend Yield: 0.89%

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 13, 2025 $0.06 05/23/2025 05/23/2025
December 05, 2024 $0.06 11/01/2024 11/01/2024
June 14, 2024 $0.06 05/23/2024 05/24/2024
December 07, 2023 $0.06 11/09/2023 11/10/2023
June 16, 2023 $0.06 05/25/2023 05/26/2023
Show more

Dividends Summary

  • Burford Capital Limited has issued 9 dividend payments over the past 4 years
  • The most recent dividend was paid 40 days ago, on June 13, 2025
  • The first recorded dividend was paid on June 18, 2021
  • The highest dividend payout was $0.12 per share
  • The average dividend over this 4 year span is $0.07 per share
  • Burford Capital Limited has decreased its dividend payments by 50.00% since 2021

Company News

  • Investors need to pay close attention to Burford Capital (BUR) stock based on the movements in the options market lately.

    Zacks Investment Research
  • These investors have a lot to talk about. And Burford Capital CEO Chris Bogart drops in to talk about the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina.

    The Motley Fool
    Featured Companies: AMZN BX DASH GS ISRG KKR LYFT MS NFLX UBER
  • Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases. Cingulate Inc. (NASDAQ: CING) gained 95.2% to $4.08. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024. Cytokinetics, Incorporated (NASDAQ: CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy. AEye, Inc. (NASDAQ: LIDR) rose 61.2% to $3.58. Vince Holding Corp. (NYSE: VNCE) jumped 42% to $3.2399. Bit Brother Limited(NASDAQ: BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday. Nxu, Inc. (NASDAQ: NXU) rose 34% to $4.18. Virax Biolabs Group Limited (NASDAQ: VRAX) gained 32% to $1.7551. Jet.AI Inc. (NASDAQ: JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday. Elicio Therapeutics, Inc. (NASDAQ: ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81. Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) gained 24.7% to ...

    Benzinga
  • Burford and plaintiffs win against Argentina, leading to an around $16 billion claim against the country. Learn why BUR may consider selling a portion of the claim.

    Seeking Alpha
  • New hires in New York, Washington and Chicago; expanded presence in DACH region New hires in New York, Washington and Chicago; expanded presence in DACH region

    GlobeNewswire Inc.
Page data last updated 07/23/2025 17:04:28 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included